MXPA04000849A - Composicion cristalina que contiene escitalopram. - Google Patents

Composicion cristalina que contiene escitalopram.

Info

Publication number
MXPA04000849A
MXPA04000849A MXPA04000849A MXPA04000849A MXPA04000849A MX PA04000849 A MXPA04000849 A MX PA04000849A MX PA04000849 A MXPA04000849 A MX PA04000849A MX PA04000849 A MXPA04000849 A MX PA04000849A MX PA04000849 A MXPA04000849 A MX PA04000849A
Authority
MX
Mexico
Prior art keywords
composition containing
crystalline composition
containing escitalopram
escitalopram
crystalline particles
Prior art date
Application number
MXPA04000849A
Other languages
English (en)
Inventor
Mahashabde Shashank
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04000849(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MXPA04000849A publication Critical patent/MXPA04000849A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Se revelan particulas cristalinas de oxalato de escitalopram cuyas particulas tienen un tamano de por lo menos 40 æm. Tambien se revela un metodo para la manufactura de dichas particulas cristalinas y composiciones farmaceuticas que contienen dichas particulas cristalinas.
MXPA04000849A 2001-07-31 2002-07-25 Composicion cristalina que contiene escitalopram. MXPA04000849A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101164 2001-07-31
PCT/DK2002/000513 WO2003011278A1 (en) 2001-07-31 2002-07-25 Crystalline composition containing escitalopram

Publications (1)

Publication Number Publication Date
MXPA04000849A true MXPA04000849A (es) 2004-05-14

Family

ID=8160647

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000849A MXPA04000849A (es) 2001-07-31 2002-07-25 Composicion cristalina que contiene escitalopram.

Country Status (40)

Country Link
US (3) US6916941B2 (es)
EP (2) EP1414435B1 (es)
JP (4) JP2005525993A (es)
KR (1) KR20040028947A (es)
CN (2) CN1311819C (es)
AR (1) AR034898A1 (es)
AT (2) ATE352546T1 (es)
AU (1) AU2002355624B2 (es)
BG (1) BG108571A (es)
BR (1) BR0206164A (es)
CA (1) CA2451915C (es)
CO (1) CO5560540A2 (es)
CY (1) CY1106413T1 (es)
DE (2) DE60217932T2 (es)
DK (2) DK1522539T3 (es)
EA (1) EA006213B1 (es)
EG (1) EG24206A (es)
ES (2) ES2280892T3 (es)
HK (1) HK1070000A1 (es)
HR (2) HRP20031073A2 (es)
HU (1) HUP0401946A2 (es)
IL (2) IL159326A0 (es)
IS (1) IS7077A (es)
MA (1) MA27349A1 (es)
ME (1) MEP2108A (es)
MX (1) MXPA04000849A (es)
MY (1) MY126238A (es)
NO (1) NO328346B1 (es)
NZ (1) NZ530157A (es)
PE (1) PE20030304A1 (es)
PL (1) PL366995A1 (es)
PT (2) PT1522539E (es)
RS (1) RS8304A (es)
SI (1) SI1414435T1 (es)
TN (1) TNSN04021A1 (es)
TR (1) TR200400189T2 (es)
UA (1) UA79930C2 (es)
UY (1) UY27404A1 (es)
WO (1) WO2003011278A1 (es)
ZA (1) ZA200309684B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195554T5 (es) 1999-04-14 2010-02-02 H. Lundbeck A/S Metodo para la preparacion de citalopram.
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
DK1522539T3 (da) 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
CA2558198A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
WO2007027612A2 (en) * 2005-08-29 2007-03-08 Teva Pharmaceutical Industries Ltd. Solid particulate tadalafil having a bimodal particle size distribution
WO2007053796A2 (en) 2005-10-14 2007-05-10 Forest Laboratories, Inc. Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
EP2086509A1 (en) * 2006-10-20 2009-08-12 Ratiopharm GmbH Escitalopram and solid pharmaceutical composition comprising the same
US20090048336A1 (en) * 2007-08-17 2009-02-19 Naveen Kumar Kolla Escitalopram oxalate powders
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (en) 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
GR20080100696A (el) 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) * 2012-01-30 2013-07-31 Carthesia Sas Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) * 2017-04-10 2018-11-14 東和薬品株式会社 エスシタロプラム医薬組成物
CN107441052A (zh) * 2017-06-21 2017-12-08 山东京卫制药有限公司 一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) * 2017-11-01 2020-03-16 한국화학연구원 에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja) 2020-06-22 2024-03-21 東和薬品株式会社 エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (es) 1965-03-18
GB1358915A (en) 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
EP0223403B1 (en) 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB9325644D0 (en) 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5683720A (en) 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AU5966196A (en) 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
PT1015416E (pt) 1997-07-08 2002-03-28 Lundbeck & Co As H Metodo para a producao de citalopram
GB9714841D0 (en) 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
US5980941A (en) 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US5840334A (en) 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
JP3813820B2 (ja) 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
EP1123284B1 (en) 1998-10-20 2003-01-08 H. Lundbeck A/S Method for the preparation of citalopram
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
ES2195554T5 (es) 1999-04-14 2010-02-02 H. Lundbeck A/S Metodo para la preparacion de citalopram.
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
JP2003510266A (ja) * 1999-09-28 2003-03-18 ハー・ルンドベック・アクチエゼルスカベット 溶融顆粒化された調合物及びこの調合物から製造された、放出が調節された投薬形
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
DK1522539T3 (da) 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram

Also Published As

Publication number Publication date
BR0206164A (pt) 2003-10-28
KR20040028947A (ko) 2004-04-03
ES2233842T3 (es) 2005-06-16
TR200400189T2 (tr) 2004-12-21
NZ530157A (en) 2007-06-29
EA200400243A1 (ru) 2004-06-24
NO20040380L (no) 2004-01-28
PT1522539E (pt) 2007-03-30
ATE286730T1 (de) 2005-01-15
JP2011195591A (ja) 2011-10-06
AU2002355624B2 (en) 2006-02-02
MEP2108A (xx) 2010-02-10
IS7077A (is) 2003-12-15
WO2003011278A1 (en) 2003-02-13
UY27404A1 (es) 2003-02-28
US6916941B2 (en) 2005-07-12
US7420069B2 (en) 2008-09-02
JP2010150283A (ja) 2010-07-08
RS8304A (en) 2006-12-15
SI1414435T1 (en) 2005-06-30
US20080305164A1 (en) 2008-12-11
US20050147674A1 (en) 2005-07-07
DK1414435T3 (da) 2005-05-09
JP5719811B2 (ja) 2015-05-20
HRPK20080410B3 (en) 2009-09-30
HK1070000A1 (en) 2005-06-10
AR034898A1 (es) 2004-03-24
CN1536997A (zh) 2004-10-13
EP1414435A1 (en) 2004-05-06
EA006213B1 (ru) 2005-10-27
CN1311819C (zh) 2007-04-25
JP5192568B2 (ja) 2013-05-08
CA2451915A1 (en) 2003-02-13
MA27349A1 (fr) 2005-06-01
ES2280892T3 (es) 2007-09-16
HUP0401946A2 (hu) 2005-01-28
CY1106413T1 (el) 2011-10-12
MY126238A (en) 2006-09-29
JP2012211186A (ja) 2012-11-01
ZA200309684B (en) 2004-12-22
PL366995A1 (en) 2005-02-07
EP1522539B1 (en) 2007-01-24
NO328346B1 (no) 2010-02-01
JP2005525993A (ja) 2005-09-02
PT1414435E (pt) 2005-05-31
ATE352546T1 (de) 2007-02-15
DK1522539T3 (da) 2007-05-07
CN1660074A (zh) 2005-08-31
UA79930C2 (en) 2007-08-10
HRP20080410A2 (en) 2008-10-31
IL159326A (en) 2010-05-31
JP4971477B2 (ja) 2012-07-11
TNSN04021A1 (en) 2006-06-01
US20030212128A1 (en) 2003-11-13
DE60217932D1 (de) 2007-03-15
EG24206A (en) 2008-10-21
DE60217932T2 (de) 2007-08-30
HRP20031073A2 (en) 2004-04-30
EP1522539A1 (en) 2005-04-13
EP1414435B1 (en) 2005-01-12
CA2451915C (en) 2010-09-21
PE20030304A1 (es) 2003-03-27
BG108571A (en) 2005-02-28
IL159326A0 (en) 2004-06-01
DE60202615T2 (de) 2006-01-12
DE60202615D1 (de) 2005-02-17
CO5560540A2 (es) 2005-09-30

Similar Documents

Publication Publication Date Title
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
BG107532A (en) Novel alpha chrystalline form of perindopril tert-butylamine salts, preparation method and pharmaceutical compositions containing same
HUP9801615A2 (hu) Szimetikon/vízmentes kalcium-foszfát-kompozíciók
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
ATE407560T1 (de) Granuliertes brotverbesserungmittel zur herstellung von teigwaren
AU2002363415A1 (en) Tightly agglomerated non-oxide particles and method for producing the same
AU2680000A (en) Cementitious compositions
IL113178A0 (en) 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use
WO2001098245A3 (en) Triphenyl compounds as interleukin-4 antagonists
AU2001278538A1 (en) Method for encapsulating fine solid particles in the form of microcapsules
DE69907119D1 (de) Pulverisierte-Sorbitol und ihr Verfahren zur Herstellung
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
AU2002219180A1 (en) Clay composition
IL161617A0 (en) Desmethyl and didesmethyl metabolites of citalopram, methods for the preparation thereof and pharmaceutical compositions containing the same
AU1238900A (en) Speckle particles and compositions containing the speckle particles
AU2003234240A1 (en) Pharmaceutical composition containing lamotrigine particles of defined morphology
AU2002246211A1 (en) Solid composition containing at least 75 % by weight of solid particles and at least one non-volatile liquid oil
MY125453A (en) Silica filler and method for its production
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
AU2002246212A1 (en) Solid composition containing colouring material and at least 75 % by weight of solid particles
SG159504A1 (en) Crystalline composition containing escitalopram oxalate
AU2002251138A1 (en) Solid composition containing solid particles comprising at least one part fibres
HUP0402418A3 (en) Substituted 1,5-diaminopentan-3-ol compounds, process for producing them, pharmaceutical compositions containing them and use thereof
AU3821999A (en) Process for the preparation of a polyvinylarene composition and polyvinylarene compositions
DE60009889D1 (de) Gipsverzögererzusammensetzung

Legal Events

Date Code Title Description
FG Grant or registration